Phreesia officer discloses two-date stock sale totaling 48,547 shares
Rhea-AI Filing Summary
Phreesia, Inc. insider Evan Roberts sold 48,547 shares under a pre-established Rule 10b5-1 plan. The Form 4 shows sales executed on 08/27/2025 (45,147 shares at a weighted-average price of $32.0199) and 08/28/2025 (3,400 shares at a weighted-average price of $32.4616). Following these transactions Roberts' reported beneficial ownership decreased from 727,768 to 724,368 shares. The filing was signed on behalf of Roberts by Allison Hoffman under power of attorney and discloses that the trades were effected pursuant to a 10b5-1 plan adopted April 15, 2025.
Positive
- Trades executed under a Rule 10b5-1 plan, indicating pre-established trading instructions and reduced appearance of opportunistic timing
- Filing includes weighted-average prices and offer to provide per-trade details, supporting transparency
Negative
- Insider disposed of 48,547 shares (45,147 on 08/27/2025 and 3,400 on 08/28/2025), reducing reported beneficial ownership
- Significant insider selling could be interpreted by some market participants as a liquidity or diversification action
Insights
TL;DR: Insider sold 48,547 shares via a Rule 10b5-1 plan, modestly reducing reported holdings.
The sales occurred over two dates at weighted-average prices of $32.0199 and $32.4616. Because the transactions were made pursuant to a 10b5-1 trading plan adopted April 15, 2025, they reflect pre-authorized dispositions rather than ad hoc sales tied to recent non-public developments. The reported post-sale beneficial ownership is 724,368 shares, down from 727,768 prior to the first sale. For investors, this is a routine disclosed insider liquidity event with limited immediate informational content on company fundamentals.
TL;DR: Use of a 10b5-1 plan and POA indicates procedural compliance with insider trading rules.
The filing explicitly states the trades were executed under a Rule 10b5-1 plan, which helps establish an affirmative defense under Rule 10b5-1(c). The filing is properly executed by power of attorney and includes footnotes disclosing the price ranges and willingness to provide transaction-level details. This presentation aligns with standard disclosure practices for director/officer sales and supports transparency in governance processes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,400 | $32.4616 | $110K |
| Sale | Common Stock | 45,147 | $32.0199 | $1.45M |
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 15, 2025. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.74 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
